New intranasal drugs against SARS-CoV-2
The extent of the current COVID-19 pandemic demands concerted efforts towards effective diagnostics, therapies and vaccines. In this direction, the EU-funded Fight-nCoV project will accelerate the preclinical development of new broad-spectrum antivirals administered via inhalation. The work builds on ongoing research on drugs that block viral entry and will test their safety and activity against SARS-CoV-2 in a macaque model of the disease. The efficacy information on these intranasal inhibitors in non-human primates will lay the foundation for the next step in the development pipeline of these drugs for human use.
Fields of science
Call for proposal
See other projects for this call